Bandaram Pharma Packtech Share Price
21.67+0.92 (+4.43%)
-39.30% past 1 Year
Bandaram Pharma Packtech Limited (Formerly Known as Shiva Medicare Limited) was incorporated in India in the year 1993. The company is engaged in the Trading of Paper. The registered office
Corporate filings & documents
Announcements
Annual Report for the FY 2025-26.
2 days agoAnnual Report for the FY 2025-26.
2 days agoNotice of AGM for the FY 2025-26 Scheduled To Be Held on 24.09.2026.
2 days agoNotice of AGM for the FY 2025-26 Scheduled To Be Held on 24.09.2026.
2 days agoChange in Management
3 weeks agoChange in Management
3 weeks agoUn-Audited Financial Results (Standalone & Consolidated) for Quater ended 30.06.2026
3 weeks agoUn-Audited Financial Results (Standalone & Consolidated) for Quater ended 30.06.2026
3 weeks agoBandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. Un-Audited standalone and consolidated financial results along with Limited Review Report for the quarter ended 30.06.2026.2. Any other business with the permission of the Chair.
4 weeks agoBandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve 1. Un-Audited standalone and consolidated financial results along with Limited Review Report for the quarter ended 30.06.2026.2. Any other business with the permission of the Chair.
4 weeks agoCertificate under Reg. 74 (5) of Sebi (DP) Regulations 2018.
1 month agoCertificate under Reg. 74 (5) of Sebi (DP) Regulations 2018.
1 month agoClarification of Price Movement
1 month agoClarification of Price Movement
1 month agoThe Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 month agoThe Exchange has sought clarification from Bandaram Pharma Packtech Ltd on July 6 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 month agoClosure of Trading Window for Un-audited Financial Results(Standalone & Consolidated) for the Quarter ending June 30 2026.
2 months agoClosure of Trading Window for Un-audited Financial Results(Standalone & Consolidated) for the Quarter ending June 30 2026.
2 months agoReceipt of Order
2 months agoReceipt of Order
2 months agoResignation of Whole-Time Director of the Company.
3 months agoResignation of Whole-Time Director of the Company.
3 months agoChange in Management
3 months agoAudited Financial Results for the Quarter and Year ended 31.03.2026
3 months agoReceipt of order
3 months agoReceipt of order
3 months agoReceipt of order
3 months agoReceipt of order
3 months agoReceipt of Order
3 months agoReceipt of Order
3 months agoAnnual Secretarial Compliance Report for FY ended 31.03.2026
3 months agoBandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial Statements (Standalone and Consolidated) along with Audit Report (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026.
3 months agoBandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial Statements (Standalone and Consolidated) along with Audit Report (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026.
3 months ago<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Bandaram Pharma Packtech Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L93090KA1993PLC159827</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 2025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Neha Kankariya</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Siva Kumar Vellanki</td></tr> <tr><td>Designation : -</td><td>CFO</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Bandaram Pharma Packtech Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L93090KA1993PLC159827</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>3.48</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Neha Kankariya <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Siva Kumar Vellanki <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoScrutinizers Report for the EGM of the company for the FY 2026-27 held on 27.04.2026
4 months agoScrutinizers Report for the EGM of the company for the FY 2026-27 held on 27.04.2026
4 months agoOutcome of EGM of the company for FY 2026-27 held on 27.04.2026
4 months agoOutcome of EGM of the company for FY 2026-27 held on 27.04.2026
4 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.
4 months agoCertificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.
4 months agoNotice of Extra-Ordinary General Meeting to be held on 27.04.2026
5 months agoOutcome of Board meeting to be held on 03.04.2026
5 months agoClosure of trading window
5 months agoClosure of trading window
5 months agoNewspaper Publication for Unaudited Financial Results for the quarter and nine months ended 31.12.2025.
6 months agoOutcome of Board meeting held on 13.02.2026
6 months agoOutcome of Board meeting held on 13.02.2026
6 months agoUnaudited Financial Results for the quarter and nine months ended 31.12.2025
6 months agoUnaudited Financial Results for the quarter and nine months ended 31.12.2025
6 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-09-22
Dividend
0.1
2024-09-20
Dividend
0.1
2023-09-22
Dividend
0.1
Company details
Registered office
601, 5th Floor, Oxford Towers Opp To Leela Palace Hotel Old Airport Road, Kodihalli Bengaluru Karnataka PIN: 560008 Tel No: 080 40952127 Fax No: NULL Email: [email protected] Internet: www.bandaram.com
Registrars
Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL
Management
Bhandaram Premsai Reddy, Promoter & Non-Executive Director
Bhandaram Sathyavathi, Promoter & Non-Executive Director
Mounika Pammi, Non Executive Independent Director
Suryaprakasa Rao Bommisetti, Non Executive Independent Director
Suman Mallu, Non Executive Independent Director
Neha Kankariya, Company Secretary & Compliance Officer
B Deepak Reddy, Chairman & Managing Director
B Deepak Reddy, Chairman & Managing Director
Eswar Reddy Putturu, Independent Director
Details
BSE 524602
NSE NULL
ISIN INE875N01036